vs

Side-by-side financial comparison of BWX Technologies, Inc. (BWXT) and PACS Group, Inc. (PACS). Click either name above to swap in a different company.

PACS Group, Inc. is the larger business by last-quarter revenue ($1.4B vs $885.8M, roughly 1.5× BWX Technologies, Inc.). BWX Technologies, Inc. runs the higher net margin — 10.5% vs 4.4%, a 6.1% gap on every dollar of revenue. On growth, BWX Technologies, Inc. posted the faster year-over-year revenue change (18.7% vs 18.4%). Over the past eight quarters, BWX Technologies, Inc.'s revenue compounded faster (21.1% CAGR vs 20.5%).

BWXT vs PACS — Head-to-Head

Bigger by revenue
PACS
PACS
1.5× larger
PACS
$1.4B
$885.8M
BWXT
Growing faster (revenue YoY)
BWXT
BWXT
+0.3% gap
BWXT
18.7%
18.4%
PACS
Higher net margin
BWXT
BWXT
6.1% more per $
BWXT
10.5%
4.4%
PACS
Faster 2-yr revenue CAGR
BWXT
BWXT
Annualised
BWXT
21.1%
20.5%
PACS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BWXT
BWXT
PACS
PACS
Revenue
$885.8M
$1.4B
Net Profit
$93.0M
$59.7M
Gross Margin
Operating Margin
10.4%
7.0%
Net Margin
10.5%
4.4%
Revenue YoY
18.7%
18.4%
Net Profit YoY
30.9%
3022.5%
EPS (diluted)
$1.02
$0.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BWXT
BWXT
PACS
PACS
Q4 25
$885.8M
$1.4B
Q3 25
$866.3M
$1.3B
Q2 25
$764.0M
$1.3B
Q1 25
$682.3M
$1.3B
Q4 24
$746.3M
$1.1B
Q3 24
$672.0M
$1.0B
Q2 24
$681.5M
$981.4M
Q1 24
$604.0M
$934.3M
Net Profit
BWXT
BWXT
PACS
PACS
Q4 25
$93.0M
$59.7M
Q3 25
$82.1M
$52.4M
Q2 25
$78.4M
$51.0M
Q1 25
$75.5M
$28.5M
Q4 24
$71.0M
$1.9M
Q3 24
$69.5M
$15.6M
Q2 24
$73.0M
$-10.9M
Q1 24
$68.5M
$49.1M
Gross Margin
BWXT
BWXT
PACS
PACS
Q4 25
Q3 25
21.8%
Q2 25
25.1%
Q1 25
24.2%
Q4 24
Q3 24
24.4%
17.1%
Q2 24
24.7%
22.3%
Q1 24
24.6%
21.2%
Operating Margin
BWXT
BWXT
PACS
PACS
Q4 25
10.4%
7.0%
Q3 25
13.1%
6.4%
Q2 25
13.4%
6.2%
Q1 25
14.2%
3.8%
Q4 24
12.4%
1.7%
Q3 24
14.4%
2.2%
Q2 24
14.5%
0.1%
Q1 24
15.4%
8.6%
Net Margin
BWXT
BWXT
PACS
PACS
Q4 25
10.5%
4.4%
Q3 25
9.5%
3.9%
Q2 25
10.3%
3.9%
Q1 25
11.1%
2.2%
Q4 24
9.5%
0.2%
Q3 24
10.3%
1.5%
Q2 24
10.7%
-1.1%
Q1 24
11.3%
5.3%
EPS (diluted)
BWXT
BWXT
PACS
PACS
Q4 25
$1.02
$0.42
Q3 25
$0.89
$0.32
Q2 25
$0.85
$0.31
Q1 25
$0.82
$0.17
Q4 24
$0.77
$-0.03
Q3 24
$0.76
$0.10
Q2 24
$0.79
$-0.07
Q1 24
$0.75
$0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BWXT
BWXT
PACS
PACS
Cash + ST InvestmentsLiquidity on hand
$499.8M
$197.0M
Total DebtLower is stronger
$353.2M
Stockholders' EquityBook value
$1.2B
$946.8M
Total Assets
$4.3B
$5.6B
Debt / EquityLower = less leverage
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BWXT
BWXT
PACS
PACS
Q4 25
$499.8M
$197.0M
Q3 25
$79.6M
$355.7M
Q2 25
$37.0M
$294.2M
Q1 25
$55.4M
$287.5M
Q4 24
$74.1M
$157.7M
Q3 24
$35.5M
$49.5M
Q2 24
$48.3M
$73.4M
Q1 24
$45.9M
$81.2M
Total Debt
BWXT
BWXT
PACS
PACS
Q4 25
$353.2M
Q3 25
Q2 25
Q1 25
Q4 24
$411.9M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
BWXT
BWXT
PACS
PACS
Q4 25
$1.2B
$946.8M
Q3 25
$1.2B
$871.3M
Q2 25
$1.2B
$806.8M
Q1 25
$1.1B
$750.2M
Q4 24
$1.1B
$709.6M
Q3 24
$1.1B
$660.0M
Q2 24
$998.5M
$572.1M
Q1 24
$946.2M
$128.0M
Total Assets
BWXT
BWXT
PACS
PACS
Q4 25
$4.3B
$5.6B
Q3 25
$3.8B
$5.6B
Q2 25
$3.7B
$5.5B
Q1 25
$3.1B
$5.5B
Q4 24
$2.9B
$5.2B
Q3 24
$2.9B
$4.5B
Q2 24
$2.8B
$3.9B
Q1 24
$2.8B
$3.9B
Debt / Equity
BWXT
BWXT
PACS
PACS
Q4 25
0.37×
Q3 25
Q2 25
Q1 25
Q4 24
0.58×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BWXT
BWXT
PACS
PACS
Operating Cash FlowLast quarter
$127.0M
$-3.4M
Free Cash FlowOCF − Capex
$56.8M
FCF MarginFCF / Revenue
6.4%
Capex IntensityCapex / Revenue
7.9%
Cash ConversionOCF / Net Profit
1.37×
-0.06×
TTM Free Cash FlowTrailing 4 quarters
$295.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BWXT
BWXT
PACS
PACS
Q4 25
$127.0M
$-3.4M
Q3 25
$143.2M
$204.8M
Q2 25
$159.0M
$52.6M
Q1 25
$50.6M
$150.2M
Q4 24
$276.9M
$64.6M
Q3 24
$32.6M
$209.2M
Q2 24
$65.9M
$34.8M
Q1 24
$33.0M
$58.8M
Free Cash Flow
BWXT
BWXT
PACS
PACS
Q4 25
$56.8M
Q3 25
$94.9M
Q2 25
$126.3M
Q1 25
$17.3M
Q4 24
$224.4M
Q3 24
$-7.7M
Q2 24
$35.5M
Q1 24
$2.6M
FCF Margin
BWXT
BWXT
PACS
PACS
Q4 25
6.4%
Q3 25
11.0%
Q2 25
16.5%
Q1 25
2.5%
Q4 24
30.1%
Q3 24
-1.1%
Q2 24
5.2%
Q1 24
0.4%
Capex Intensity
BWXT
BWXT
PACS
PACS
Q4 25
7.9%
Q3 25
5.6%
Q2 25
4.3%
Q1 25
4.9%
Q4 24
7.0%
Q3 24
6.0%
Q2 24
4.5%
Q1 24
5.0%
Cash Conversion
BWXT
BWXT
PACS
PACS
Q4 25
1.37×
-0.06×
Q3 25
1.74×
3.91×
Q2 25
2.03×
1.03×
Q1 25
0.67×
5.28×
Q4 24
3.90×
33.78×
Q3 24
0.47×
13.39×
Q2 24
0.90×
Q1 24
0.48×
1.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BWXT
BWXT

Nuclear Component Program$436.4M49%
Nuclear Manufacturing$134.8M15%
Cost Plus Fee$116.1M13%
Uranium And Nuclear Services$103.8M12%
Commercial Operations$49.0M6%
Commercial Operations Segment$33.7M4%
Transferred At Point In Time$1.3M0%

PACS
PACS

Segment breakdown not available.

Related Comparisons